Amalgamated Bank’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Amalgamated Bank’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,845	Closed	-$59K	–	3005
2023 Q3	$59K	Hold	8,845	–	–	﹤0.01%	2183
2023 Q2	$80K	Sell	8,845 -3,169	-26%	-$27.9K	﹤0.01%	2144
2023 Q1	$87K	Sell	12,014 -2,672	-18%	-$19.8K	﹤0.01%	2112
2022 Q4	$107K	Buy	14,686 +2,953	+25%	+$21.9K	﹤0.01%	2102
2022 Q3	$91K	Buy	11,733 +176	+2%	+$1.49K	﹤0.01%	2191
2022 Q2	$79K	Buy	+11,557	New	+$88.4K	﹤0.01%	2275

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Amalgamated Bank's PNT Position: Q4 2023 in Review

Amalgamated Bank sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 8,845 shares — an estimated $59K sold.

Amalgamated Bank first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $107K in Q4 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Amalgamated Bank reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Amalgamated Bank sold 8,845 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $59K.
Amalgamated Bank first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Amalgamated Bank's POINT Biopharma Global Inc. Common Stock position peaked at $107K in Q4 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Amalgamated Bank's 13F filing for Q4 2023, filed 6 Feb 2024.